Dec 10, 2018
Marinus Pharmaceuticals (MRNS) surges on positive data from Ganaxolone trial
Marinus Pharmaceuticals (MRNS) surges on positive data from Ganaxolone trial
Shares of Marinus Pharmaceuticals (MRNS) jumped after the pharma company reported positive data from the Phase 2 ganaxolone clinical trial in women with postpartum depression (PPD). The announcement excited the investors and sent the stock upwards by 18% in the pre-market trading session.
In the past three months, MRNS stock had dropped 25% and in the past one year, it had plunged 40%.
(This…
View On WordPress